HCPCS J7612
Levalbuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, concentrated form, 0.5 mg
HCPCS Information
- HCPCS Code: J7612
- The Healthcare Common Procedure Coding System (HCPCS) is a set of unique alphanumeric codes used to report medical procedures and services to healthcare programs like Medicare and Medicaid. HCPCS codes are used in conjunction with NDC codes for billing and medical documentation puporses. For instance, HCPCS J7612 identifies the type of service or supply used while any of the 3 NDC codes below could be used to specify the exact drug used.
- Short Description
- Levalbuterol non-comp con
- Long Description
- Levalbuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, concentrated form, 0.5 mg
- Pricing Indicator
- Service not separately priced by part B (e.G., services not covered, bundled, used by part a only, etc.)
- Multiple Pricing Indicator
- Not applicable as HCPCS not priced separately by part B (pricing indicator is 00) or value is not established (pricing indicator is '99')
- Coverage Description
- Special coverage instructions apply
- BETOS Type of Service
- Drugs Administered through DME
- Medicare Payment Limit
- $0.30
- Medicare Co-Insurance Percentage
- 20.000%
- HCPCS Classification
- List of HCPCS codes for: Drugs Administered Other Than Oral Method, Chemotherapy Drugs (J-codes)
HCPCS Crossover to NDC Codes
The NDC codes below allow precise billing based on the specific manufacturer and medication used:
| NDC | Proprietary Name | Non-Proprietary Name | Dosage Form | Route Name | Company Name | Status | |
|---|---|---|---|---|---|---|---|
| 0378-6993 | Levalbuterol | Levalbuterol | Solution, Concentrate | Respiratory (inhalation) | Mylan Pharmaceuticals Inc. | ACTIVE | |
| 17478-171 | Xopenex | Akorn | INACTIVATED | ||||
| 65862-942 | Levalbuterol | Levalbuterol | Solution, Concentrate | Respiratory (inhalation) | Aurobindo Pharma Limited | ACTIVE |
